- Home
- SOHU vs CRVS Comparison
SOHU vs CRVS Comparison
Compare SOHU & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHU
- CRVS
- Stock Information
- Founded
- SOHU 1996
- CRVS 2014
- Country
- SOHU China
- CRVS United States
- Employees
- SOHU N/A
- CRVS N/A
- Industry
- SOHU EDP Services
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- SOHU Technology
- CRVS Health Care
- Exchange
- SOHU Nasdaq
- CRVS Nasdaq
- Market Cap
- SOHU 468.1M
- CRVS 459.0M
- IPO Year
- SOHU 2000
- CRVS 2016
- Fundamental
- Price
- SOHU $15.77
- CRVS $5.79
- Analyst Decision
- SOHU Strong Buy
- CRVS Strong Buy
- Analyst Count
- SOHU 1
- CRVS 4
- Target Price
- SOHU $20.00
- CRVS $15.00
- AVG Volume (30 Days)
- SOHU 71.7K
- CRVS 547.2K
- Earning Date
- SOHU 11-11-2025
- CRVS 11-11-2025
- Dividend Yield
- SOHU N/A
- CRVS N/A
- EPS Growth
- SOHU N/A
- CRVS N/A
- EPS
- SOHU 4.10
- CRVS N/A
- Revenue
- SOHU $548,588,000.00
- CRVS N/A
- Revenue This Year
- SOHU N/A
- CRVS N/A
- Revenue Next Year
- SOHU $2.29
- CRVS N/A
- P/E Ratio
- SOHU $3.82
- CRVS N/A
- Revenue Growth
- SOHU N/A
- CRVS N/A
- 52 Week Low
- SOHU $7.79
- CRVS $2.54
- 52 Week High
- SOHU $17.24
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- SOHU 52.34
- CRVS 56.88
- Support Level
- SOHU $15.49
- CRVS $5.64
- Resistance Level
- SOHU $16.21
- CRVS $6.09
- Average True Range (ATR)
- SOHU 0.49
- CRVS 0.34
- MACD
- SOHU -0.08
- CRVS -0.05
- Stochastic Oscillator
- SOHU 38.74
- CRVS 50.00
About SOHU Sohu.com Limited
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).